in animals are ambiguous. Some studies favour a postsynaptic action on neurons. 4 More recent studies in spinal animals favour the hypothesis of a presynaptic effect on Ia afferents.' 6 Contrasting with these results, studies in spastic human patients, 7 8 have failed to demonstrate a presynaptic effect. In these studies, presynaptic inhibition on Ia fibres was only assessed by vibratory inhibition of MSR. Two facts led us to re-examine the mechanisms responsible for the inhibition of MSR by intrathecal baclofen in humans. Firstly, intrathecal baclofen allows a much stronger inhibition than oral administration,'-3 9-12 thus allowing a more reliable study. Secondly, Hultborn et all3 have recently described a new method which permits a more direct study of Ia presynaptic inhibition in humans.
Patients and methods
This investigation was performed in 15 patients, aged 18-55. This therapy was undertaken because all of them had severe spasticity and disabling spasms of spinal origin. The main characteristics of the patients' clinical state are summarised in the table. Fourteen had a traumatic spinal cord lesion, of which six were clinically complete, and eight incomplete. One had spastic paraparesis due to multiple sclerosis. The duration of the lesion was at least six months. All gave their consent after being informed of the experimental aim of the electrophysiological study. At the time of the experimental session, the patients were free from pressure sores, urinary tract infection or any other medical complication and had no oral treatment of spasticity. During the recording sessions, the patients sat in their wheelchairs or lay on a bed with their legs in the same position throughout the experimental session. The H-reflex was tested on the soleus muscle. Surface electrodes were used both for stimulation and recording. Rectangular current pulses of 1 ms duration were used for stimulation, and were applied using a unipolar electrode. The active electrode was placed in the popliteal fossa to stimulate the tibial nerve. The reflex responses were measured as the peak-to-peak amplitude of the evoked muscle action potential. These potentials were recorded with two non-polarisable disc electrodes (09 mm diameter; inter-electrode distance 2 cm) placed over the bellies of the soleus muscle (below the gastrocnemius muscles). The electromyographical responses were measured using an analog digital converter linked to a microcomputer. It has been demonstrated that the first 0 5 ms of this heteronymous Ia facilitation from quadriceps to soleus is mediated exclusively through a monosynaptic pathway and is not contaminated by any Ib or polysynaptic Ta effect."3 Accordingly, the timing was adjusted in order to make the conditioning afferent volley arrive at the spinal level no more than 0-5 ms before the test soleus H-reflex. The conditioning stimulus was delivered after the test stimulus, because the distance from the femoral triangle to the spinal cord is shorter than the distance from the popliteal fossa to the spinal cord. First, the shortest conditioning-test interval (using 0 1 ms steps) at which facilitation of the soleus H-reflex could be elicited was determined. The interval used in the following part of the experiment was 0-2-0-3 ms longer to obtain sizeable facilitation due only to the monosynaptic Ia EPSP.
The amount of facilitation before baclofen (control situation) was compared with that obtained every 10 minutes after the intrathecal injection. Under these conditions, the reflex facilitation depended only on the size of the conditioning EPSP evoked by heteronymous Ia stimulation. A constant conditioning stimulus should elicit an EPSP of constant size in motor neurons, and thus a constant amount of reflex facilitation, unless the amount of presynaptic inhibition of Ia fibres changes; a decrease in the facilitation may be ascribed to an increase in presynaptic inhibition of the heteronymous Ia fibres from quadriceps to soleus. It has been shown'4 '5 that the susceptibility of an H-reflex to facilitation varies with the size of the unconditioned reflex. After baclofen injection, however, the soleus Hreflex was depressed. To maintain a constant size (10-15% of Mm2,) of the reference (unconditioned) H-reflex despite MSR inhibition, the test stimulus intensity had to be adjusted (increased).
Every 10 minutes, a series of at least 20 unconditioned and 20 conditioned H-reflexes was recorded with stimuli being delivered every 4s. variable. As the table shows, in six patients, the effect appeared rapidly and, when the appropriate dose was given, the inhibition was complete within less than one hour. In four cases, more than two hours were necessary to obtain a complete inhibition of the H-reflex. The minimal dose necessary to abolish the H-reflex and the time to peak effect were not correlated with the HmaxiMmax ratio before injection, or with the level of the lesion, and did not differ whether the spinal lesion was clinically complete or not. This inter-individual variability may be due to patients' susceptibility to the drug but modifications of CSF flow may-contribute to this variability, at least in paraplegia of traumatic origin. Effect on soleus H-reflex conditioned by Ia afferent stimulation The effect of a vibratory stimulus was studied in eight subjects. Weak vibratory inhibition (less than 20%) was observed in only two of them (cases 8 and 11). The injection of baclofen did not enhance vibratory inhibition in those two, nor did it make it appear in the other six patients (fig 2) . The effect on the soleus H-reflex Ia heteronymous facilitation was studied in five patients, the test H-reflex being deliberately set In four patients (cases 8, 11, 13, 14) , the same findings were observed: facilitation was not altered by the injection, as long as the H-reflex was not profoundly inhibited (Hmax/ Mmax ratio higher than 25%). ,ug. The control soleus Hmax reflex was 62% of the Mmax value, and it progressively decreased after injection. The test H-reflex was increased 54% by the heteronymous Ia volley before injection and this amount of facilitation remained stable despite significant inhibition of the MSR: for an Hmax/Mmax ratio of 25%, the amount of facilitation was still 44%. For stronger H-reflex inhibition, however, the facilitation weakened significantly and then disappeared. Figure 4 summarises the results in the five patients, showing the size of test and conditioned soleus H-reflexes before and after an injection producing a reduction of the H max/ Mmax ratio to 25%. In four patients, the amplitude of the facilitation was not significantly modified by an injection of baclofen. In one patient (case 10), the facilitation decreased after injection. It should be noted, however, that the variability of the test H-reflex was greater in this patient than in the other four. In this same patient, the injection was made by a percutaneous lumbar puncture, whereas an implantable pump was used in the other four. These technical problems may contribute to the variable results obtained in this case. 16 
Discussion
Baclofen is known to be efficient in reducing The figure muscle tone and flexor or extensor spasms in ) patients suffering from Meunier and Pierrot-Deseilligny'9 have suggested that presynaptic inhibition on these two types of Ta fibres directed to soleus a-motor neurons could be mediated by the same interneurons.
In animal experiments and studies in vitro, there is no agreement on the presynaptic or postsynaptic effect of baclofen.4 Initial studies20 and, more recently, Edwards et ar and Jimenez et aP, conclude that baclofen's main site of action is presynaptic, by reducing the probability of release of neurotransmitter, without any effect on the membrane time constant or EPSP decay. Nevertheless, postsynaptic effects have also been demonstrated by many authors who showed that baclofen has a hyperpolarising action, dependent on dose and concentration on some mammalian central neurons, associated with an increase in postsynaptic potassium conductance. 4 Most data have been obtained in experimental conditions that are quite remote from human clinical conditions: firstly, these studies have only been performed on acute spinal animals, and secondly, intrathecal administration has not been studied in animal preparations.
In summary, our results suggest that intrathecal baclofen in chronic spinal patients inhibits the soleus H-reflex by a postsynaptic effect, at least until the Hmax/Mmax ratio is higher than 25%. This effect may be exerted directly on the motor neuron itself, or by a postsynaptic inhibitory mechanism that is released by baclofen.
